Browse > Article
http://dx.doi.org/10.7742/jksr.2020.14.3.319

Comparison of Efficacy of Overlapped Versus Long Eluting Stent in Acute Myocardial Infarction Patients with Diffuse Long Lesion  

Kim, Won Hyo (Department of Radiology, Dongshin University)
Kim, In Soo (Department of Radiology, Dongshin University)
Kong, Chang gi (Department of Radiology, Dongshin University)
Han, Jae Bok (Department of Radiology, Dongshin University)
Publication Information
Journal of the Korean Society of Radiology / v.14, no.3, 2020 , pp. 319-336 More about this Journal
Abstract
The purpose of this study was to compare the outcomes of two interventional methods, overlapping drug-eluting stents (DES) and long DES, for long-term clinical outcomes in patients with acute myocardial infarction (AMI). A total of 438 patients with AMI (65.9±11.0 years, 306 males) from June 2008 to March 2019 who had diffuse long coronary artery lesion, more than 30mm were divided into two groups; group I (overlapped DES group; n=140) and group II (long DES group; n=298). We compared the incidences of major adverse cardiac events [MACEs; cardiac death, myocardial infaction (MI), target lesion revascularization (TLR) and stent thrombosis (ST)] during 12 months between the two groups. Everolimus-eluting stent was more commonly used in group II than in group I (28.1% vs. 51.8% p<0.001). Mean lesion diameter was slightly longer in group II (3.1±0.3mm vs. 3.2±0.3mm, p=0.042), and prevalence of ACC/AHA lesion type C was higher in group I (41.7% vs. 25.4%, p<0.001). Incidences of MACEs during 12 months were higher in group I than group II (18.5% vs. 14.4%, p=0.034). The rates of cardiac death (2.1% vs. 4.4%, p=0.667), MI (5.0% vs. 2.7%, p=0.260) and stent thrombosis rate (0.7% vs. 1.7%, p=0.669) were similar between the two groups. However, TLR rate was higher in group I (10.7% vs. 5.6%, p=0.041). In multivariate logistic regression analysis, presence of diabetes mellitus [Hazard ratio (HR) 2.383, 95% confidence interval (CI) 1.332-4.260, p=0.003] and use of paclitaxel-eluting stent (HR) 2.367, 95% CI 1.371-4.086, p=0.002) were independent predictors of 12-month MACEs, without significant differences in prevalence between the two groups. In AMI patients with diffuse long lesion, TLR rate was higher in the overlapped DES group during 12-month follow-up. Presence of diabetes and use of paclitaxel-eluting stent were independent predictors of MACEs.
Keywords
Drug eluting stent; Acute myocardial infarction; Major adverse cardiac events;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S. B. King, S. C. Smith, J. W. Hirshfeld, A. K. Jacobs, D. A. Morrison, Williams DO; 2005 WRITING COMMITTEE MEMBERS, T. E. Feldman, M. J. Kern, W. W. O'Neill, "2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee", Circulation, Vol. 117, pp. 261-295, 2008. https://doi.org/10.1161/CIRCULATIONAHA.107.188208   DOI
2 A. Messori, S. Trippoli, "Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance", Heart, Vol. 95, pp. 84, 2009.   DOI
3 K. D. Dawkins, E. Grube, G. Guagliumi, A. P. Banning, K. Zmudka, A. Colombo, L. Thuesen, K. Hauptman, J. Marco, W. Wijns, J. J. Popma, J. Koglin, M. E. Russell, "Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice", Circulation, Vol. 112, pp. 3306-3313, 2005. https://doi.org/10.1161/circulationaha.105.552190   DOI
4 D. R. Holmes, M. B. Leon, J. W. Moses, J. J. Popma, D. Cutlip, M. Midei, D. Snead, R. E. Kuntz, "Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis", Circulation, Vol. 109, pp. 634-640, 2004. https://doi.org/10.1161/01.cir.0000112572.57794.22   DOI
5 A. V. Finn, F. D. Kolodgie, J. Harnek, L. J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D. K. Weber, H. K. Gold, R. Virmani, "Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus or paclitaxel-eluting stents", Circulation, Vol. 112, pp. 270-278, 2005. https://doi.org/10.1161/circulationaha.104.508937   DOI
6 H. Doi, A. Maehara, G. S. Mintz, K. Tsujita, T. Kubo, C. Castellanos, J. Liu, J. Yang, C. Oviedo, J. Aoki, M. B. Leon, "Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture", The American Journal of Cardiology, Vol. 103, pp. 818-823, 2009. https://doi.org/10.1016/j.amjcard.2008.11.051   DOI
7 E. Grube, L. Buellesfeld, "BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease", Expert Review of Medical Devices, Vol. 3, pp. 731-741, 2006. http://dx.doi.org/10.1586/17434440.3.6.731   DOI
8 M. Ostojic, D. Sagic, R. Jung, "The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study", Catheterization and Cardiovascular Interventions, Vol. 72, pp. 901-908, 2008. https://doi.org/10.1002/ccd.21775   DOI
9 T. Chechi, G. Vittori, G. G. Biondi Zoccai, "Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION)", Journal of Interventional Cardiology, Vol. 20, pp. 282-291, 2007. https://doi.org/10.1111/j.1540-8183.2007.00270.x   DOI
10 S. Bangalore, S. Kumar, M. Fusaro, "Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient years of follow-up from randomized trials", Circulation, Vol. 125, pp. 2873-2891, 2012. https://doi.org/10.1161/circulationaha.112.097014   DOI
11 K. Y. Chen, S. W. Rha, L. Wang, "Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis", JACC Cardiovascular Interventions, Vol. 5, pp. 936-945, 2012. https://doi.org/10.1016/j.jcin.2012.05.009   DOI
12 M. Degertekin, C. A. Arampatzis, P. A. Lemos, "Very long sirolimus-eluting stent implantation for de novo coronary lesions", The American Journal of Cardiology, Vol. 93, pp. 826-829, 2004. https://doi.org/10.1016/j.armjcard.2003.12.018   DOI
13 A. R. Gruntzig, A. Senning, W. E. Siegenthaler, "Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty", New England journal of medicine, Vol. 301, pp. 61-68, 1979. https://doi.org/10.1056/nejm197907123010201   DOI
14 K. Ahmed, M. H. Jeong, R. Chakraborty, Y. J. Hong, D. S. Sim, S. Ahmed, S. H. Hwang, M. G. Lee, J. C. Par, J. C. Kang, "Safety and efficacy of overlapping homogenous drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction Registry", Journal of Korean Medical Science, Vol. 27, pp. 1339-1346, 2012. http://dx.doi.org/10.3346/jkms.2012.27.11.1339   DOI
15 Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology(ESC), P. G. Steg, S. K. James, "ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation", European Heart Journal, Vol. 33, pp. 2569-2619, 2012. http://dx.doi.org/10.1093/eurheartj/ehs215   DOI
16 P. W. Serruys, M. C. Morice, A. P. Kappetein, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease", New England journal of medicine, Vol. 360, pp. 961-972, 2009. http://dx.doi.org/10.1056/NEJMoa0804626   DOI
17 W. Casscells, D. Engler, J. T. Willerson, "Mechanisms of restenosis", Texas Heart Institute Journal, Vol. 21, pp. 68-77, 1994. https://doi.org/10.1016/0735-1097(93)90241-R
18 P. W. Serruys, P. de Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P, Materne, J. Belardi, U. Sigwart, A. Colombo, J. J. Goy, P. van den Heuvel, J. Delcan, M. Morelet, "A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group", New England journal of medicine, Vol. 331, pp. 489-495, 1994. https://doi.org/10.1056/nejm199408253310801   DOI
19 B. Azarbal, J. W. Currier, "Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer", Journal of the American College of Cardiology, Vol. 47, pp. 182-183, 2006. https://doi.org/10.1016/j.jacc.2005.09.045   DOI
20 W. Kim, M. H. Jeon, J. Y. Cho, "The preventive effect on instent restenosis of overlapped drug-eluting stents for diffuse coronary artery disease", Korean Circulation Journal, Vol. 36, pp. 17-1723, 2006. https://doi.org/10.4070/kcj.2006.36.1.17   DOI
21 M. H. Shishehbor, R. Amini, R. E. Raymond, A. A. Bavry, S. J. Brener, S. R. Kapadia, P. L. Whitlow, S. G. Ellis, D. L. Bhatt, "Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents", American Heart Journal, Vol. 155, pp. 1075-1080, 2008. https://doi.org/10.1016/j.ahj.2008.01.017   DOI
22 M. Degertekin, C. A. Arampatzis, P. A. Lemos, F. Saia, A. Hoye, J. Daemen, K. Tanabe, C. H. Lee, S. J. Hofma, G. Sianos, "Very long sirolimus-eluting stent implantation for de novo coronary lesions", The American Journal of Cardiology, Vol. 93, pp. 826-829, 2004. https://doi.org/10.1016/j.amjcard.2003.12.018   DOI
23 P. W. Serruys, S. Silber, S. Garg, R. J. van Geuns, G. Richardt, P. E. Buszman, H. Kelbaek, A. J. van Boven, S. H. Hofma, A. Linke, "Comparison of zotarolimus-eluting and everolimus-eluting coronary stents", New England journal of medicine, Vol. 363, pp. 136-144, 2010. https://doi.org/10.1056/NEJMoa1004130   DOI
24 S. Y. Lim, M. H. Jeong, S. J. Hong, D. S. Lim, J. Y. Moon, Y. J. Hong, J. H. Kim, Y. K. Ahn, J. C. Kang, "Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis", Circulation Journal, Vol. 72, pp. 463-468, 2008. https://doi.org/10.1253/circj.72.463   DOI
25 N. Mori, M. Nishino, D. Nakamura, Y. Lee, T. Yoshimura, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, H. Morita, J. Tanouchi, Y. Yamada, "Different neointimal response to overlapping segments between everolimus-eluting stents and sirolimus-eluting stents-optical coherence tomographic study", Circulation, Vol. 124, pp. A12546, 2011. https://doi.org/10.1093/eurheartj/eht309.2673
26 V. Farooq, P. Vranckx, L. Mauri, D. E. Cutlip, J. Belardi, S. Silber, P. Widimsky, M. Leon, H. M. Garcia-Garcia, P. W. Serruys, "Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program", Heart, Vol. 99, pp. 626-633, 2013. https://doi.org/10.1136/heartjnl-2012-303368   DOI
27 C. J. O'Sullivan, G. G. Stefanini, L. Raber, D. Heg, M. Taniwaki, B. Kalesan, T. Pilgrim, T. Zanchin, P. Juni, S. Windecker, "Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents", EuroIntervention, Vol. 9, pp. 1076-1084, 2004. https://doi.org/10.4244/EIJV919A182   DOI
28 H. Otake, Y. Honda, M. Yamasaki, I. Tsujino, T. Shimohama, R. Sakurai, T. Hasegawa, K. Waseda, J. Ako, P. J. Fitzgerald, "Vascular Response to Overlapping Everolimus-Eluting Stents : Comparison With Paclitaxel-Eluting Stents", Circulation Journal, Vol. 74, pp. 1023-1025, 2010. https://doi.org/10.1253/circj.cj-10-0052   DOI
29 A. J. Kirtane, A. Gupta, S. Iyengar, J. W. Moses, M. B. Leon, R. Applegate, B. Brodie, E. Hannan, K. Harjai, L. O. Jensen, "Safety and efficacy of drugeluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies", Circulation, Vol. 119, pp. 3198-3206, 2009. https://doi.org/10.1161/CIRCULATIONAHA.108.826479   DOI
30 N. Mori, N. Okamoto, A. Tanaka, M. Yano, N. Makino, Y. Egami, R. Shutta, Y. Sakata, J. Tanouchi, M. Nishino, "Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings", The American Journal of Cardiology, Vol. 117, pp. 1724-1728, 2016. https://doi.org/10.1016/j.amjcard.2016.03.004   DOI
31 K. Ahmed, M. H. Jeong, R. Chakraborty, "Comparison of zotarolimus- and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention", Journal of Cardiology, Vol. 64, pp. 273-278. 2014. https://doi.org/10.1016/j.jjcc.2014.02.002   DOI
32 S. Windecker, P. W. Serruys, S. Wandel, "Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial", Lancet, Vol. 372, pp. 1163-1173, 2008. https://doi.org/10.1016/S0140-6736(08)61244-1   DOI
33 M. Natsuaki, K. Kozuma, T. Morimoto, H. Shiomi, T. Kimura, "Two-year outcome of a randomized trial comparing second generation drug-eluting stents using biodegradable or durable polymer", The Journal of the American Medical Association, Vol. 311, pp. 2125-2127, 2014. https://doi.org/10.1001/jama.2014.3584   DOI
34 G. G. Stefanini, R. A. Byrne, P. W. Serruys, "Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials", European Heart Journal, Vol. 33, pp. 1214-1222, 2012. https://doi.org/10.1093/eurheartj/ehs086   DOI
35 H. Le Breton, E. F. Plow, E. J. Topol, "Role of platelets in restenosis after percutaneous coronary revascularization", Journal of the American College of Cardiology, Vol. 28, pp. 1643-1651, 1996. https://doi.org/10.1016/S0735-1097(96)00417-2   DOI
36 D. L. Fischman, M. B. Leon, D. S. Baim, R. A. Schatz, M. P. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, M. Nobuyoshi, M. Cleman, R. Heuser, D. Almond, P. S. Teirstein, R. D. Fish, A. Colombo, J. Brinker, J. Moses, A. Shaknovich, J. Hirshfeld, S. Bailey, S, Ellis, R. Rake, S. Goldberget, "A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators", New England journal of medicine, Vol. 331, pp. 496-501, 1994. https://doi.org/10.1056/nejm199408253310802   DOI
37 S. J. Park, W. H. Shim, D, S. Ho, A. E. Raizner, S. W. Park, M. K. Hong, C. W. Lee, D. Choi, Y. Jang, R. Lam, N. J. Weissman, G. S. Mintz, "A paclitaxel-eluting stent for the prevention of coronary restenosis", New England journal of medicine, Vol. 348, pp. 1537-1545, 2003. https://doi.org/10.1056/nejmoa021007   DOI
38 E. Regar, G. Sianos, P. W. Serruys, "Stent development and local drug delivery", British Medical Bulletin, Vol. 59, pp. 227-248, 2001. https://doi.org/10.1093/bmb/59.1.227   DOI
39 R. Virmani, G. Guagliumi, A. Farb, "Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious", Circulation, Vol. 109, pp. 701-705, 2004. https://doi.org/10.1161/01.cir.0000116202.41966.d4   DOI
40 G. G. Stefanini, B. Kalesan, P. W. Serruys, "Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (leaders): 4 year follow-up of a randomised non-inferiority trial", The Lancet, Vol. 378, pp. 1940-1948, 2011. https://doi.org/10.1016/S0140-6736(11)61672-3   DOI
41 X. F. Tang, Y. L. Ma, Y. Song, J. J. Xu, Y. Yao, C. He, H. H. Wang, P. Jiang, L. Jiang, R. Liu, Z. Gao, X. Y. Zhao, S. B. Qiao, Y. J. Yang, R. L. Gao, B. Xu, J. Q. Yuan, "Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study", Cardiovasc Diabetol, Vol. 17, pp. 114, 2018. https://doi.org/10.1186/s12933-018-0758-0   DOI
42 A. V. Finn, F. D. Kolodgie, J. Harnek, "Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-eluting stents or paclitaxel-eluting stents", Circulation, Vol. 112, pp. 270-278, 2005. https://doi.org/10.1161/circulationaha.104.508937   DOI
43 H. Vaknin-Assa, A. Assali, S. Ukabi, E. I. Lev, R. Kornowski, "Stent thrombosis following drug-eluting stent implantation A single-center experience", Cardiovascular Revascularization Medicine, Vol. 8, pp. 243-247, 2007. https://doi.org/10.1016/j.carrev.2007.07.001   DOI
44 P. W Serruys, M. C. Morice, A. P. Kappetein, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease", New England journal of medicine Vol. 360, pp. 961-972. 2009. https://doi.org/10.1056/nejmoa0804626   DOI
45 P. W. Serruys, D. P. Foley, M. J. Suttorp, "A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study", Journal of the American College of Cardiology, Vol. 39, pp. 393-399, 2002. https://doi.org/10.1016/s0735-1097(01)01760-0
46 I. Iakovou, T. Schmidt, E. Bonizzoni, "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents", The Journal of the American Medical Association, Vol. 293, pp. 2126-2130, 2005. https://doi.org/10.1001/jama.293.17.2126   DOI
47 P. K. Kuchulakanti, W. W. Chu, R. Torguson R, "Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-eluting stents and paclitaxel-eluting stents", Circulation, Vol. 113, pp. 1108-1113, 2006. https://doi.org/10.1161/circulationaha.105.600155   DOI
48 L. Raber, P. Juni, L. Loffel, S. Wandel, S. Cook, P. Wenaweser, M. Togni, R. Vogel, C. Seiler, F. Eberli, T. Luscher, B. Meier, S. Windecker, "Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation", Journal of the American College of Cardiology, Vol. 55, pp. 1178-1188, 2010. https://doi.org/10.1016/j.jacc.2009.11.052   DOI
49 C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M. C. Morice, A. Schömig, M. E. Pfisterer, G. W. Stone, M. B. Leon, J. S. de Lezo, "Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis", The Lancet, Vol. 370, pp. 937-948, 2007. https://doi.org/10.1016/s0140-6736(07)61444-5   DOI
50 H. Kitabata, J. P. Loh, L. K. Pendyala, S. Badr, D. Dvir, I. M. Barbash, S. Minha, R. Torguson, F. Chen, L. F. Satler, W. O. Suddath, K. M. Kent, A. D. Pichard, R. Waksman, "Safety and efficacy outcomes of overlapping second generation everolimus-eluting stents versus first-generation drug eluting stents", The American Journal of Cardiology, Vol. 112, pp. 1093-1098, 2013. https://doi.org/10.1016/j.amjcard.2013.05.054   DOI
51 A. Kaltoft, L. O. Jensen, M. Maeng, H. H. Tilsted, P. Thayssen, M. Bottcher, J. F. Lassen, L. R. Krusell, K. Rasmussen, K. N. Hansen, "2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)", Journal of the American College of Cardiology, Vol. 53, pp. 658-664, 2009. https://doi.org/10.1016/j.jacc.2008.09.058   DOI
52 S. K. James, U. Stenestrand, J. Lindback, J. Carlsson, F. Scherstén, T. Nilsson, L. Wallentin, B. Lagerqvist, "Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden", New England journal of medicine, Vol. 360, pp.1933-1945, 2009. https://doi.org/10.1056/nejmoa0809902   DOI